Boxer Capital, LLC Ionis Pharmaceuticals Inc Transaction History

Boxer Capital, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$40.53 - $50.7 $12.6 Million - $15.8 Million	-312,000 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$44.08 - $55.05 $6.08 Million - $7.6 Million	-138,000 Reduced 30.67%	312,000 $13.8 Million
Q4 2017 Feb 14, 2018	BUY	$50.3 - $64.39 $22.6 Million - $29 Million	450,000	450,000 $22.6 Million

403

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $4.87B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Boxer Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Boxer Capital, LLC with notifications on news.